• Explore /
  • Poster
  • / Phase Ib of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC).

Phase Ib of anticancer stem cell antibody OMP-59R5 (anti-Notch2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC).

Abstract Poster

Authors

Eileen M. O'Reilly

Eileen Mary O'Reilly

Memorial Sloan-Kettering Cancer Center, New York, NY

Eileen Mary O'Reilly , Lon S. Smith , Johanna C. Bendell , Fatima A. Rangwala , William Schmidt , Joe Stephenson , Ann Kapoun , Lu Xu , Dawn Hill , Lei Zhou , Jakob Dupont , Allen Lee Cohn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01647828

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 220)

DOI

10.1200/jco.2014.32.3_suppl.220

Abstract #

220

Poster Bd #

A49

Abstract Disclosures

Similar Posters

First Author: Eileen Mary O'Reilly

First Author: Joon Oh Park

First Author: Guifang Guo

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

First Author: Yan-Shen Shan